Prediabetes

Although COVID-19 remained a popular topic among Healio Primary Care readers in 2021, other stories that discussed diabetes screening and physician suicide also generated significant attention.

Since the start of the COVID-19 pandemic, many patients have not received preventive care, and “it is vital that they get caught up now,” the chair of the U.S. Preventive Services Task Force told Healio Primary Care.

The U.S. Preventive Services Task Force issued draft guidance today that states there is insufficient evidence to make a recommendation for or against prediabetes and type 2 diabetes screening in asymptomatic children and adolescents.

November is American Diabetes Month, a time to raise awareness about the importance of prevention, detection and management, according to the American Diabetes Association.

Diabetes duration, including prediabetes, is independently associated with risk for incident heart failure, with greater risks for women and Black adults, according to data presented at the Heart in Diabetes CME Conference.

Diabetes duration, including prediabetes, is independently associated with risk for incident heart failure, with greater risks for women and Black adults, according to data presented at the Heart in Diabetes CME Conference.

The U.S. Preventive Services Task Force has published its final guidance on prediabetes and type 2 diabetes screening, lowering the recommended age in asymptomatic, nonpregnant adults who are overweight or obese to 35 years.

Patients with prediabetes who participated in shared medical appointments lost more weight and experienced greater reductions in HbA1C and BP levels than their counterparts who received usual care, a retrospective cohort study showed.

Adults with prediabetes were more likely to have an MI and other CV events compared with those who had normal blood glucose levels, according to a presentation at the American College of Cardiology Scientific Session.

The U.S. Preventive Services Task Force released a draft recommendation that, if adopted, would lower the age to start screening adults with overweight or obesity for prediabetes and type 2 diabetes from 40 to 35 years.